Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04572399 · ClinicalTrials.gov registry record · NA
UVA Light Device to Treat COVID-19
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04572399: Completed NA study, sponsored by Cedars-Sinai Medical Center.
NCT04572399 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04572399, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
Primary Outcome
Change of viral load in upper airway in patients admitted to hospital for COVID-19
Interventions
- DEVICE UV Light Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2020-12-28 |
| Phase | NA |
What the finished NCT04572399 record still lists
NCT04572399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which UV Light Treatment is the first listed.
NCT04572399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04572399 about?
NCT04572399 is a clinical study titled "UVA Light Device to Treat COVID-19". This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
What is the current status of trial NCT04572399?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-10-30. Estimated completion is 2020-12-28.
What interventions are being tested in trial NCT04572399?
The interventions under investigation include: UV Light Treatment (DEVICE).
Who is sponsoring clinical trial NCT04572399?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04572399's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI